Efficacy of Haemophilus influenzae type-b conjugate vaccine in the Valencian community of Spain. Vaccine failures;Vacunacion frente a Haemophilus influenzae tipo b en la comunidad Valenciana: Efectividad vacunal y fallos vacunales

Anales Espanoles de Pediatria

Volumn 48, Issue 4, 1998, Pages 352-354

  Morant Gimeno, A ^a,b   Diez Domingo J ^a,c,i   Resales Marza, A ^a,d   Moreno Munoz R ^a,e   Lopez Garcia P ^a,d   Herrero Galiana, A ^a,f   Gimeno Cardona, C ^a,g   Brines Solanes, J ^a,h  

^a Instituto de Vacunas de Valencia

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Unitat d'Investigacio Trinitat   (Spain)

^d Servicio de Microbiología   (Spain)

^e Pediat H Gen de Castellón   (Spain)

^f Hospital Verge Dels Lliris   (Spain)

^g Servicio de Microbiología

^h Pediat H Clin de Valencia

ⁱ UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Haemophilus influenzae type b; Vaccine efficacy; Vaccine failures

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; MALE; PROSPECTIVE STUDY; SPAIN; TREATMENT FAILURE; VACCINATION; CASE REPORT; IMMUNOLOGY; INFANT; INFLUENZA; PRESCHOOL CHILD;

CHILD, PRESCHOOL; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; SPAIN; VACCINATION;

EID: 0032039214     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Comité de vacunas de la AEP (Asociación Española de Pediatría; Aristegui J, coordinador). Manual de vacunas. Madrid: Egraf, S.A., 1996.
2. Shinefield HR, Black S. Postlicensure surveillance for Haemophilus influenzae type h invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up. Pediatr Infec Dis J 1995; 14:978-981.
3. Booy R, Heath PT, Slack MPE, Begg N, Moxon ER. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet 1997; 349:1197-1202.
4. Herceg A. Haemophilus influenzae type b cases in Australia from 1 July 1993 to 30 June 1994 - results of the Hib case reporting scheme including immunisation status and vaccine failures. Comm Dis Intell 1995; 19:86-90.
5. Eskola J, Käyhty H. Ten years' experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland. Rev Med Microbiol 1996; 7:231-241.
6. Prats G, Domínguez A, Salleras LI. Haemophilus influenzae: Epidemiología de la enfermedad invasiva. Med Clin (Barc) 1996; 107:422-428.
7. Morant A, Díez J, Gimeno C, de la Muela N, Pereiró I, Brines J. Enfermedad invasora por Haemophilus influenzae tipo b en la Comunidad Valenciana. Med Clin (Barc). En prensa.
8. Ward J, Lieberman JM, Cocho SL. Haemophilus influenzae vaccines. En: Plotkin SA, Mortimer EA, editores. Vaccines. Philadelphia: Saunders, 1994; 337-386.
9. Booy R, Moxon ER. Immunisation of infants against Haemophilus influenzae type b in the UK. Arch Dis Child 1991; 66:1251-1254.
10. a ed. Barcelona: Marketing Trends SL, 1994.
11. Halloran ME, Harber M, Longini IM, Struchiner CJ. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol 1991; 133:323-331.
12. Harber M, Longini IM, Halloran ME. Measures of the effects of vaccination in a randomly mixing population. Int J Epidemiol 1991; 20:300-310.
13. Guallar-Castillón P, Jiménez FJ, Rucio C, Guallar E. Revisión de los datos de incidencia de enfermedad invasiva y de meningitis por Haemophilus influenzae en niños menores de 5 años en España. An Esp Pediatr 1997; 47:263-268.